Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice.

por Aamdal, S., Fodstad, O., Nesland, J. M., Pihl, A.
Publicado 1985

Prostatic carcinoma: a multivariate analysis of prognostic factors.

por Berner, A., Harvei, S., Tretli, S., Fosså, S. D., Nesland, J. M.
Publicado 1994

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.

por Berner, A., Nesland, J. M., Waehre, H., Silde, J., Fosså, S. D.
Publicado 1993

Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX.

por Noodt, B. B., Berg, K., Stokke, T., Peng, Q., Nesland, J. M.
Publicado 1996

Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells.

por Saeter, G., Schwarze, P. E., Nesland, J. M., Seglen, P. O.
Publicado 1989

Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light

por Noodt, B B, Berg, K, Stokke, T, Peng, Q, Nesland, J M
Publicado 1999

Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies

por Pedersen, K B, Nesland, J M, Fodstad, Ø, Mælandsmo, G M
Publicado 2002

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence

por Hernes, E, Fosså, S D, Berner, Aa, Otnes, B, Nesland, J M
Publicado 2004

DNA ploidy in primary testicular cancer.

por Fosså, S. D., Nesland, J. M., Pettersen, E. O., Amellem, O., Waehre, H., Heimdal, K.
Publicado 1991

Prognostic significance of TP53 alterations in breast carcinoma.

por Andersen, T. I., Holm, R., Nesland, J. M., Heimdal, K. R., Ottestad, L., Børresen, A. L.
Publicado 1993

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

por Skomedal, H., Kristensen, G., Helland, A., Nesland, J. M., Kooi, S., Børresen, A. L., Holm, R.
Publicado 1995

Colony forming ability of human breast carcinomas: lack of prognostic significance.

por Ottestad, L., Tveit, K. M., Hannisdal, E., Skrede, M., Nesland, J. M., Gundersen, S., Pihl, A.
Publicado 1989

EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer

por Boye, K, Nesland, J M, Sandstad, B, Haugland Haugen, M, Mælandsmo, G M, Flatmark, K
Publicado 2012

TP53 allele loss, mutations and expression in malignant melanoma.

por Flørenes, V. A., Oyjord, T., Holm, R., Skrede, M., Børresen, A. L., Nesland, J. M., Fodstad, O.
Publicado 1994

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family histor...

por Børresen, A. L., Ottestad, L., Gaustad, A., Andersen, T. I., Heikkilä, R., Jahnsen, T., Tveit, K. M., Nesland, J. M.
Publicado 1990

P53 mutations in gastric carcinomas.

por Seruca, R., David, L., Holm, R., Nesland, J. M., Fangan, B. M., Castedo, S., Sobrinho-Simões, M., Børresen, A. L.
Publicado 1992

Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.

por Fosså, S. D., Berner, A. A., Jacobsen, A. B., Waehre, H., Kvarstein, B., Urnes, T., Ogreid, P., Johansen, T. E., Silde, J., Nesland, J. M.
Publicado 1993

Cultivation of human breast carcinoma in soft agar. Experience with 237 fresh tumour specimens.

por Ottestad, L., Tveit, K. M., Høifødt, H. K., Nesland, J. M., Vaage, S., Høie, J., Lund, E., Pihl, A.
Publicado 1988

Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H).

por Pettersen, E. O., Larsen, R. O., Dornish, J. M., Børretzen, B., Juul, M. E., Aastveit, T. E., Nesland, J. M., Rofstad, E. K., Oftebro, R.
Publicado 1993

Disseminated tumour cells as a prognostic biomarker in colorectal cancer

por Flatmark, K, Borgen, E, Nesland, J M, Rasmussen, H, Johannessen, H-O, Bukholm, I, Rosales, R, Hårklau, L, Jacobsen, H J, Sandstad, B, Boye, K, Fodstad, Ø
Publicado 2011